Outlook Therapeutics
OTLK
OTLK
70 hedge funds and large institutions have $32.6M invested in Outlook Therapeutics in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
29% less capital invested
Capital invested by funds: $45.9M → $32.6M (-$13.3M)
Holders
70
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.67M | |
| 2 | +$1.24M | |
| 3 | +$790K | |
| 4 |
Two Sigma Investments
New York
|
+$678K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$286K |
Top Sellers
| 1 | -$621K | |
| 2 | -$315K | |
| 3 | -$266K | |
| 4 |
LNC
Lincoln National Corp
Radnor,
Pennsylvania
|
-$203K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$110K |